Health Care Costs Associated to Type of Feeding in the First Year of Life

Background: Breastfeeding is associated with lower risk of infectious diseases, leading to fewer hospital admissions and pediatrician consultations. It is cost saving for the health care system, however, it is not usually estimated from actual cohorts but via simulation studies. Methods: A cohort of 970 children was followed-up for twelve months. Data on mother characteristics, pregnancy, delivery and neonate characteristics were obtained from medical records. The type of neonate feeding at discharge, 2, 4, 6, 9 and 12 months of life was reported by the mothers. Infectious diseases diagnosed in the first year of life, hospital admissions, primary care and emergency room consultations and drug treatments were obtained from neonate medical records. Health care costs were attributed using public prices and All Patients Refined–Diagnosis Related Groups (APR–DRG) classification. Results: Health care costs in the first year of life were higher in children artificially fed than in those breastfed (1339.5€, 95% confidence interval (CI): 903.0–1775.0 for artificially fed vs. 443.5€, 95% CI: 193.7–694.0 for breastfed). The breakdown of costs also shows differences in primary care consultations (295.7€ for formula fed children vs. 197.9€ for breastfed children), emergency room consultations (260.1€ for artificially fed children vs. 196.2€ for breastfed children) and hospital admissions (791.6€ for artificially fed children vs. 86.9€ for breastfed children). Conclusions: Children artificially fed brought about more health care costs related to infectious diseases than those exclusively breastfed or mixed breastfed. Excess costs were caused in hospital admissions, primary care consultations, emergency room consultations and drug consumption.

Download Full-text

Major Depressive Disorder, Somatic Pain, and Health Care Costs in an Urban Primary Care Practice

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v67n0809 ◽

2006 ◽

Vol 67 (08) ◽

pp. 1232-1239 ◽

Cited By ~ 50

Author(s):

Marc J. Gameroff ◽

Mark Olfson

Keyword(s):

Primary Care ◽

Health Care ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Health Care Costs ◽

Primary Care Practice ◽

Care Practice ◽

Major Depressive ◽

Somatic Pain ◽

Care Costs

Download Full-text

AB1106 First-Year Health Care Costs for Early Arthritis in Daily Practice Related to Medication Non-Adherence and Other Determinants

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.3036 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 1270.2-1271

Author(s):

A. Pasma ◽

L. Schenk ◽

R. Timman ◽

A. van 't Spijker ◽

C.W. Appels ◽

...

Keyword(s):

Health Care ◽

Health Care Costs ◽

Daily Practice ◽

Early Arthritis ◽

First Year ◽

Care Costs

Download Full-text

Costing Methodology and Key Drivers of Health Care Costs Within Economic Analyses in Musculoskeletal Community and Primary Care Services: A Systematic Review of the Literature

Journal of Primary Care & Community Health ◽

10.1177/2150132719899763 ◽

2020 ◽

Vol 11 ◽

pp. 215013271989976

Author(s):

Roanna Burgess ◽

James Hall ◽

Annette Bishop ◽

Martyn Lewis ◽

Jonathan Hill

Keyword(s):

Primary Care ◽

Health Care ◽

Health Care Costs ◽

Community Settings ◽

Outpatient Visits ◽

Key Drivers ◽

Gp Visits ◽

Economic Analyses ◽

Care Costs

Background: Identifying variation in musculoskeletal service costs requires the use of specific standardized metrics. There has been a large focus on costing, efficiency, and standardized metrics within the acute musculoskeletal setting, but far less attention in primary care and community settings. Objectives: To ( a) assess the quality of costing methods used within musculoskeletal economic analyses based primarily in primary and community settings and ( b) identify which cost variables are the key drivers of musculoskeletal health care costs within these settings. Methods: Medline, AMED, EMBASE, CINAHL, HMIC, BNI, and HBE electronic databases were searched for eligible studies. Two reviewers independently extracted data and assessed quality of costing methods using an established checklist. Results: Twenty-two studies met the review inclusion criteria. The majority of studies demonstrated moderate- to high-quality costing methods. Costing issues included studies failing to fully justify the economic perspective, and not distinguishing between short- and long-run costs. Highest unit costs were hospital admissions, outpatient visits, and imaging. Highest mean utilization were the following: general practitioner (GP) visits, outpatient visits, and physiotherapy visits. Highest mean costs per patient were GP visits, outpatient visits, and physiotherapy visits. Conclusion: This review identified a number of key resource use variables that are driving musculoskeletal health care costs in the community/primary care setting. High utilization of these resources (rather than high unit cost) appears to be the predominant factor increasing mean health care costs. There is, however, need for greater detail with capturing these key cost drivers, to further improve the accuracy of costing information.

Download Full-text

Health care costs of depression in primary care patients in The Netherlands

Family Practice ◽

10.1093/fampra/cmq033 ◽

2010 ◽

Vol 27 (5) ◽

pp. 542-548 ◽

Cited By ~ 10

Author(s):

J. E. Bosmans ◽

M. C. de Bruijne ◽

M. R. de Boer ◽

H. van Hout ◽

P. van Steenwijk ◽

...

Keyword(s):

Primary Care ◽

Health Care ◽

The Netherlands ◽

Health Care Costs ◽

Primary Care Patients ◽

Care Costs

Download Full-text

Primary care as a means of decreasing health care costs

Health SA Gesondheid ◽

10.4102/hsag.v9i4.181 ◽

2004 ◽

Vol 9 (4) ◽

Author(s):

Martie M Van Deventer ◽

Susan P Hattingh ◽

Marthie C Bezuidenhout

Keyword(s):

Primary Care ◽

Health Care ◽

Health Care Costs ◽

Full Text ◽

Development Programme ◽

Health Objectives ◽

Care Costs

The study was focussed at furthering the health objectives of the Government’s Reconstruction and Development Programme in the area of primary care. Opsomming Die studie was gemik op die bevordering van die gesondheidsdoelwitte van die regering se Herkonstruksie enOntwikkelingsprogram (“Reconstruction and Development Programme”) op die gebied van primêre sorg. *Please note: This is a reduced version of the abstract. Please refer to PDF for full text.

Download Full-text

The impact of non-compliance with imatinib (IM) therapy on health care costs

Journal of Clinical Oncology ◽

10.1200/jco.2006.24.18_suppl.6083 ◽

2006 ◽

Vol 24 (18_suppl) ◽

pp. 6083-6083

Author(s):

H. J. Henk ◽

S. K. Thomas ◽

W. Feng ◽

B. Jean-Francois ◽

G. A. Goldberg ◽

...

Keyword(s):

Health Care ◽

Health Care Costs ◽

Medication Possession Ratio ◽

Underlying Disease ◽

Imatinib Therapy ◽

First Year ◽

The Impact ◽

Initial Starting ◽

The Relationship ◽

Care Costs

6083 Background: While compliance to drug therapy is vital to receive optimal patient benefits, the costs of delivering adequate medical care for cancer patients remain an important consideration for society and payers. This study examined the relationship between compliance with IM therapy and health care costs for patients with CML and GIST. Methods: Claims data from 6/1/01–3/31/04 from a US health plan were used to identify non-Medicare IM-treated patients with a CML or GIST diagnosis who had continuous pharmacy and medical benefits in the 3 months prior and 12 months following initiation of IM therapy. Compliance was defined by medication possession ratio (MPR=total days IM supply in the first year ÷365) and patients were stratified into three segments by MPR (<50%, 50–90%, 90–100%). Total health care costs include hospital, laboratory testing, office, ER, and pharmacy charges. Disease-related health care costs were also analyzed. Multivariate analyses were used to examine the relationship between MPR and first-year health care costs, controlling for age, sex, number of medications, initial starting dose, diagnosis (CML or GIST), year of initial IM fill, and complications due to underlying disease. Results: Total 878 IM-treated patients were identified of whom 413 had at least 15 months of continuous eligibility. Of these, 307 were non-Medicare CML or GIST patients. Total health care costs per patient in the first year of therapy in MPR < 50%, 50–90%, and 90–100% groups were $163,828, $53,924, and $40,924 respectively (p < 0.001). The corresponding numbers for disease-related health care costs were $103,118, $36,436, and $34,086 (p<0.001). Controlling for the variables listed above, a 10% increase in MPR is associated with a 5% decrease in total health care costs (p=0.021). Similar association was found between MPR and disease-related health care costs. Conclusions: Improved compliance with imatinib therapy is associated with decreased total health care costs and disease-related health care costs. Improving compliance to imatinib therapy may not only optimize clinical outcomes but may also reduce the overall societal burden of health care costs associated with cancer. [Table: see text]

Download Full-text

How Much Do Mental Health and Substance Use/Addiction Affect Use of General Medical Services? Extent of Use, Reason for Use, and Associated Costs

The Canadian Journal of Psychiatry ◽

10.1177/0706743716664884 ◽

2016 ◽

Vol 62 (1) ◽

pp. 48-56 ◽

Cited By ~ 19

Author(s):

Kathryn Graham ◽

Joyce Cheng ◽

Sharon Bernards ◽

Samantha Wells ◽

Jürgen Rehm ◽

...

Keyword(s):

Mental Health ◽

Primary Care ◽

Health Care ◽

Substance Use ◽

Health Care Costs ◽

Emergency Departments ◽

Primary Care Physicians ◽

Service Use ◽

Cross Sectional ◽

Care Costs

Objective: To measure service use and costs associated with health care for patients with mental health (MH) and substance use/addiction (SA) problems. Methods: A 5-year cross-sectional study (2007-2012) of administrative health care data was conducted (average annual sample size = 123,235 adults aged >18 years who had a valid Ontario health care number and used at least 1 service during the year; 55% female). We assessed average annual use of primary care, emergency departments and hospitals, and overall health care costs for patients identified as having MH only, SA only, co-occurring MH and SA problems (MH+SA), and no MH and/or SA (MH/SA) problems. Total visits/admissions and total non-MH/SA visits (i.e., excluding MH/SA visits) were regressed separately on MH, SA, and MH+SA cases compared to non-MH/SA cases using the 2011-2012 sample ( N = 123,331), controlling for age and sex. Results: Compared to non-MH/SA patients, MH/SA patients were significantly ( P < 0.001) more likely to visit primary care physicians (1.82 times as many visits for MH-only patients, 4.24 for SA, and 5.59 for MH+SA), use emergency departments (odds, 1.53 [MH], 3.79 [SA], 5.94 [MH+SA]), and be hospitalized (odds, 1.59 [MH], 4.10 [SA], 7.82 [MH+SA]). MH/SA patients were also significantly more likely than non-MH/SA patients to have non-MH/SA-related visits and accounted for 20% of the sample but over 30% of health care costs. Conclusions: MH and SA are core issues for all health care settings. MH/SA patients use more services overall and for non-MH/SA issues, with especially high use and costs for MH+SA patients.

Download Full-text